High-value compounds from the molluscs of marine and estuarine ecosystems as prospective functional food ingredients: An overview
K Chakraborty, M Joy - Food Research International, 2020 - Elsevier
Extensive biodiversity and availability of marine and estuarine molluscs, along with their
their wide-range of utilities as food and nutraceutical resources developed keen attention of …
their wide-range of utilities as food and nutraceutical resources developed keen attention of …
Molluscan biological and chemical diversity: Secondary metabolites and medicinal resources produced by marine molluscs
K Benkendorff - Biological Reviews, 2010 - Wiley Online Library
The phylum Mollusca represents an enormous diversity of species with eight distinct
classes. This review provides a taxonomic breakdown of the published research on marine …
classes. This review provides a taxonomic breakdown of the published research on marine …
Development of highly stabilized curcumin nanoparticles by flash nanoprecipitation and lyophilization
The influence of critical operating parameters on the Flash Nanoprecipitation (FNP) and
resulting material properties of curcumin (CUR) nanoparticles has been evaluated using a …
resulting material properties of curcumin (CUR) nanoparticles has been evaluated using a …
[HTML][HTML] Sepia Ink Oligopeptide Induces Apoptosis in Prostate Cancer Cell Lines via Caspase-3 Activation and Elevation of Bax/Bcl-2 Ratio
F Huang, Z Yang, D Yu, J Wang, R Li, G Ding - Marine drugs, 2012 - mdpi.com
Sepia ink oligopeptide (SIO) is a tripeptide extracted from Sepia ink. To test the hypothesis
that SIO inhibits prostate cancer by inducing apoptosis, the effects of SIO on the proliferation …
that SIO inhibits prostate cancer by inducing apoptosis, the effects of SIO on the proliferation …
Anticancer activity of an oligopeptide isolated from hydrolysates of Sepia ink
D Guo-Fang, FF HUANG, Y Zui-Su, YU Di… - Chinese Journal of …, 2011 - Elsevier
Aim To investigate the antitumor effect of peptides from Sepia ink by enzymatic hydrolysis.
Methods Sepia ink was hydrolyzed with trypsin to prepare peptides; hydrolysates were …
Methods Sepia ink was hydrolyzed with trypsin to prepare peptides; hydrolysates were …
Self-assembling nanoparticles of dually hydrophobic prodrugs constructed from camptothecin analogue for cancer therapy
Y Zhang, R Yin, G Wu, M Yu, J Liu, X Wang… - European Journal of …, 2020 - Elsevier
Nanomedicines have shown success in cancer therapy in recent years because of their
excellent solubility in aqueous solution and drug accumulation through controlled release in …
excellent solubility in aqueous solution and drug accumulation through controlled release in …
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
A dose-escalation, phase I study evaluated the safety, pharmacokinetics,
pharmacogenomics, and efficacy of ES-285, a novel agent isolated from a marine mollusc …
pharmacogenomics, and efficacy of ES-285, a novel agent isolated from a marine mollusc …
Spisulosine (ES-285) given as a weekly three-hour intravenous infusion: results of a phase I dose-escalating study in patients with advanced solid malignancies
P Schöffski, H Dumez, R Ruijter, B Miguel-Lillo… - Cancer chemotherapy …, 2011 - Springer
Purpose Spisulosine is a marine compound that showed antitumor activity in preclinical
studies. We report results of a phase I trial performed in patients with advanced solid tumors …
studies. We report results of a phase I trial performed in patients with advanced solid tumors …
[PDF][PDF] Homospisulosine induced apoptosis in cervical carcinoma cells is associated with phosphorylation of Bcl-2 and up-regulation of p27/Kip1
MB Pilátová, N Nosálová, G Ockajakova… - Journal of Applied …, 2023 - jab.zsf.jcu.cz
Abstract Spisulosine (1-deoxysphinganine) is a sphingoid amino alcohol isolated from the
sea clams that showed potent antiproliferative activity against a broad spectrum of solid …
sea clams that showed potent antiproliferative activity against a broad spectrum of solid …
A phase I dose-escalating study of ES-285, a marine sphingolipid-derived compound, with repeat dose administration in patients with advanced solid tumors
E Vilar, V Grünwald, P Schöffski, H Singer… - Investigational new …, 2012 - Springer
Summary Background ES-285 (Spisulosine) is a novel marine compound with antitumor
activity in preclinical studies. A phase I study was performed in patients with advanced solid …
activity in preclinical studies. A phase I study was performed in patients with advanced solid …